Systems Study on the Antirheumatic Mechanism of Tibetan Medicated-Bath Therapy Using Wuwei-Ganlu-Yaoyu-Keli

Table 2

Genes encoding drug targets for FDA approved anti-RA drugs that appear in the network modules.

Module	Drug target	Drug	Drug class
()	JAK1	Tofacitinib	DMARDs
	JAK2	Tofacitinib	DMARDs
()	IL1B	Canakinumab	Biotech agents
	IL6R	Tocilizumab	Biotech agents
	LTA	Etanercept	Biotech agents
	TNF	Etanercept	Biotech agents
		Adalimumab	Biotech agents
		Infliximab	Biotech agents
		Golimumab	Biotech agents
		Certolizumab pegol	Biotech agents
		Chloroquine	DMARDs
	TNFRSF1B	Etanercept	Biotech agents
()	IL1R1	Anakinra	Biotech agents
()	PTK2B	Leflunomide	DMARDs
()	MAPK3	Sulindac	NSAIAs
()	CHUK	Sulfasalazine	DMARDs
	IKBKB	Sulfasalazine	DMARDs
		Auranofin	DMARDs
()	PDPK1	Celecoxib	NSAIAs
()	BCL2	Ibuprofen	NSAIAs